Search Prime Grants

HT94252510473

Project Grant

Overview

Grant Description
In situ engineering of oncobacteria to remodel the colorectal cancer microenvironment
Awardee
Eligo Bioscience
Funding Goals
PEER REVIEWED CANCER RESEARCH PROGRAM
Grant Program (CFDA)
12.420 - Military Medical Research and Development
Awarding / Funding Agency
Defense Health Agency (DHA) [DoD]
Place of Performance
France
Geographic Scope
Foreign
Related Opportunity
DoD Peer Reviewed Cancer, Idea Award (HT942524PRCRPIA)
Eligo Bioscience was awarded Project Grant HT94252510473 worth $436,398 from Defense Health Agency in September 2025 with work to be completed primarily in France. The grant has a duration of 2 years and was awarded through assistance program 12.420 Military Medical Research and Development. The Project Grant was awarded through grant opportunity DoD Peer Reviewed Cancer, Idea Award.

Status
(Ongoing)

Last Modified 7/31/25

Period of Performance
9/1/25
Start Date
8/31/27
End Date
4.0% Complete

Funding Split
$436.4K
Federal Obligation
$0.0
Non-Federal Obligation
$436.4K
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to HT94252510473

Additional Detail

Award ID FAIN
HT94252510473
SAI Number
None
Award ID URI
None
Awardee Classifications
For-Profit Organization (Other Than Small Business)
Awarding Office
HT9425 ARMY MED RES ACQ ACTIVITY
Funding Office
HT0989 CONG DIR MED RES PRGM / CDMRP - MM
Awardee UEI
DRH1MFHJWYG3
Awardee CAGE
FB7U2
Performance District
Not Applicable
Modified: 7/31/25